OBJECTIVE: To determine whether pravastatin compared with usual care reduces all-cause mortality in older， moderately hypercholesterolemic， hypertensive parti...
作者：国际循环网 发布于：2004-08-10
BACKGROUND: Cardiovascular disease is a common cause of morbidity and death in persons with renal insufficiency. Although 3-hydroxy-3methylglutaryl coenzyme A r...
CONTEXT: Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and mortality. However， the optimal strategy and target level for lipid...
BACKGROUND: Lipid-lowering therapy with statins reduces the risk of cardiovascular events， but the optimal level of low-density lipoprotein (LDL) cholesterol i...
BACKGROUND: Lower blood cholesterol concentrations have consistently been found to be strongly associated with lower risks of coronary disease but not with lowe...
CONTEXT: Although cholesterol-reducing treatment has been shown to reduce fatal and nonfatal coronary disease in patients with coronary heart disease (CHD)， it...
ESC专访 | 临床实践中，冠状动脉疾病的..
再添力证：早期联合降脂治疗可显著改善..
ESC专访丨陈桢玥教授：EPA可在高糖环境..
ESC热评 | 陶凌教授：无症状重度主动脉..
京公网安备 11010502033353号 增值电信业务经营许可证:京ICP证150541号
